Allarity Therapeutics Inc (ALLR) concluded trading on Thursday at a closing price of $1.03, with 3.74 million shares of worth about $3.85 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -92.29% during that period and on December 19, 2024 the price saw a gain of about 6.17%. Currently the company’s common shares owned by public are about 4.43M shares, out of which, 3.96M shares are available for trading.
Stock saw a price change of 0.00% in past 5 days and over the past one month there was a price change of -17.60%. Year-to-date (YTD), ALLR shares are showing a performance of -99.69% which decreased to -99.71% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.90 but also hit the highest price of $378.00 during that period. The average intraday trading volume for Allarity Therapeutics Inc shares is 408.24K. The stock is currently trading -6.15% below its 20-day simple moving average (SMA20), while that difference is down -21.55% for SMA50 and it goes to -96.69% lower than SMA200.
Allarity Therapeutics Inc (NASDAQ: ALLR) currently have 4.43M outstanding shares and institutions hold larger chunk of about 0.49% of that.
The stock has a current market capitalization of $4.57M and its 3Y-monthly beta is at 0.26. It has posted earnings per share of -$883.45 in the same period. It has Quick Ratio of 2.75 while making debt-to-equity ratio of 0.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ALLR, volatility over the week remained 20.31% while standing at 10.04% over the month.
